Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Julphar
Merck
Healthtrust
Mallinckrodt
Colorcon
Moodys
US Department of Justice
Teva

Generated: July 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020992

« Back to Dashboard

NDA 020992 describes CENESTIN, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. Additional details are available on the CENESTIN profile page.

The generic ingredient in CENESTIN is estrogens, conjugated synthetic a. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated synthetic a profile page.
Summary for 020992
Tradename:CENESTIN
Applicant:Teva Branded Pharm
Ingredient:estrogens, conjugated synthetic a
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020992
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992 NDA Physicians Total Care, Inc. 54868-1432 E 54868-1432-0
CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992 NDA Physicians Total Care, Inc. 54868-1432 E 54868-1432-1

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jun 21, 2002TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 24, 1999TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.9MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 24, 1999TE:RLD:Yes

Expired US Patents for NDA 020992

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-004 Mar 13, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-001 Jun 21, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-002 Mar 24, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-003 Mar 24, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Colorcon
Chubb
Farmers Insurance
Medtronic
Argus Health
Moodys
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.